Treatment and survival of Merkel cell carcinoma since 1993: a population-based cohort study in the Netherlands

•Merkel cell carcinoma (MCC) is a potentially lethal skin-cancer with a rapidly increasing incidence in the Netherlands. The 5-year survival of 63% did not improve over time and is worse for males, elderly and advanced disease. Our results emphasise need for implementation of new therapies and research in this field.

http://bit.ly/2S7T1IB